The ELISA test for the scheduled death of T1 cells (human DP-1) quantifies human PD-1 in serum, plasma or human cell culture medium. The dosage will only recognize natural and recombinant human PD-1. Principle of...
The ELISA test for the scheduled death of T1 cells (human DP-1) quantifies human PD-1 in serum, plasma or human cell culture medium. The dosage will only recognize natural and recombinant human PD-1. Method Principle The ELISA solid phase sandwich test of human PD-1 (immuno-enzymatic test) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-vested in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bound to immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
PD-1 (Programmed Cell Death Protein 1, PCDP-1, CD279) is a cell surface receptor of approximately 273-290 amino acids of length that inhibits T-cell-mediated immune responses. PD-1 can bind two different but associated ligands, PDL-1 and PDL-2. When binding to either of these ligands, PD-1 signals inhibit the activation of the immune response in the absence of danger signals, such as lipopolysaccharides (LPS) associated with bacteria or pathogens. Evidence of this is observed in PD1-nullen mice with hyper-activated immune systems and autoimmune diseases. In addition, expression of this gene in mice is induced in thymus when anti-CD3 antibodies are injected and a large number of thymocytes undergo apoptosis. Mouse with a BALB/c-level gene developed dilated cardiomyopathy and died from congestive heart failure.
Sensitivity
Sensitivity of the dosage: 1.14 pg/ml.
Measurement range
Dose range: 2.34-150 pg/ml.
Duration of dosing
Total duration of dosing: 3 h 30 min.
Reproducibility
Coefficient of variation intra-dose 3.2%, inter-dose 6.4%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15571727 |
| Specifications |
| Accession number | Q15116 |
| Dose range | 2.34-150 pg/ml |
| Sensitivity of the dosage | 1.14 pg/ml |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Type of sample | Serum, Surnatant, Supernatant |
| Target species | Human |
| For use with (application) | ELISA |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 5133 |
| Gene symbol(s) | CD279,PD-1,PD1,SLEB2,hPD-1,hPD-l,hSLE1 |
| Coefficient of inter-dose variation | 6.4% |
| Coefficient of intra-dose variation | 3.2% |
| Contents of kits | 96-well pre-coated plate, Stalion, Sample thinner, Dose buffer concentrate, Biotinylated detection antibody, Wash pad, Chromogen, Stop solution, Adhesive Plate Covers, Adhesive Plate Covers |
| Marker or dye | HRP |
| Quantity | 96 Tests |
| Regulatory status | RUO |
| Synonym | Protein of cellular death programmed 1, PDCD1, CD729 |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 50 μl; Serum, 50 μl; Supernatant, 50 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 3 h 30 min |
Origin and customs
| Manufacturer ref. | BMS2214 |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.